Journal Club

HomeMembersAssemblies and SectionsAssembliesThoracic OncologyJournal Club ▶ Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial
Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial

Webinar date: October 26, 2016

 

This Journal Club was sponsored by ATS Tobacco Action Committee, Assembly on Thoracic Oncology (TO) and Assembly on Behavioral Sciences and Health Services Research (BSHSR)

Moderators

Michelle Eakin. PhD

Johns Hopkins University
Website Director, Assembly on Behavioral Science and Health Services Research
Tobacco Action Committee

Presented by

A. Eden Evins, MD, MPH
Harvard Medical School

Discussion Panelist

Katrina Steiling, MD, MSc
Boston University
Website Director, Assembly on Thoracic Oncology

Hasmeena Kathuria, MD
Tobacco Action Committee

Last Reviewed: November 2016